Biote Corp. cash flow statement
In fiscal 2025, Biote Corp.'s operations generated $35.2m of cash; it spent $5.0m on capital projects, leaving free cash flow of $30.2m. It returned $1.7m in dividends and $3.4m through buybacks.
Cash flow statement
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 34 | −9 | 27 | 45 | 35 | 24 |
| Depreciation and amortisation | 1 | 2 | 3 | 4 | 4 | 3 |
| Stock-based pay | — | 82 | 9 | 9 | 9 | 8 |
| Capital spending | 1 | 0 | 0 | 6 | 5 | 4 |
| Free cash flow | 32 | −9 | 27 | 39 | 30 | 20 |
| Free cash flow after stock pay | — | −92 | 17 | 30 | 21 | 12 |
| Dividends paid | 11 | 13 | 9 | 5 | 2 | 1 |
| Share buybacks | — | — | — | 6 | 3 | — |
| Shares issued | 0 | — | — | — | — | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 16 | 12 | 6 | 7 | 14 | 8 | 4 | −1 |
| Depreciation and amortisation | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
| Stock-based pay | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Capital spending | 2 | 2 | 2 | 2 | 0 | 1 | 0 | 3 |
| Free cash flow | 14 | 11 | 5 | 5 | 14 | 6 | 4 | −4 |
| Free cash flow after stock pay | 12 | 9 | 3 | 3 | 11 | 4 | 2 | −6 |
Compare with peers
- Organigram Global Inc. cash flow
- Kamada LTD cash flow
- Cronos Group Inc. cash flow
- Amarin Corp plc\uk cash flow
- Heron Therapeutics, Inc. cash flow
Head to head: BTMD vs OGIBTMD vs KMDABTMD vs CRONAMRN vs BTMD
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies